It looks like the National Institutes of Health COVID-19 Treatment Guidelines Panel could finally start listening…
“January 6th, 2021: FLCCC Alliance Invited to the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel to Present Latest Data on Ivermectin”
Snippet #1:
“On January 6, 2021, Drs. Pierre Kory and Paul Marik, founding members of the Front Line COVID-19 Critical Care Alliance (FLCCC), appeared before the National Institutes of Health COVID-19 Treatment Guidelines Panel. The panel, which is in the process of reviewing the rapidly emerging data
on the role of ivermectin in the prevention and treatment of COVID-19, invited Drs. Kory and Marik to present the latest data, along with Dr. Andrew Hill—a senior research fellow at the University of Liverpool, who was hired by UNITAID to provide research for the World Health Organization (WHO).”
Snippet #2:
“In order to save thousands who will die while waiting for their turn to receive the vaccine, it is imperative that treatment guidelines issued by the NIH over four months ago be updated to reflect the strength of the data for ivermectin in prophylaxis, early treatment, and late-stage disease,” said Dr. Kory, FLCCC president, following the hearing.”
Click here to see the full press release:
https://covid19criticalcare.com/wp-content/uploads/2021/01/FLCCC-PressRelease-NIH-C19-Panel-FollowUp-Jan7-2021.pdf
[print-me printicon=”false” tag=”button” title=”Print this Post” /]